CENTRAL NERVOUS SYSTEM ENTEROVIRAL INFECTION

This adverse event was reported 23 times

These drugs are most commonly taken by patients reporting CENTRAL NERVOUS SYSTEM ENTEROVIRAL INFECTION:

# Drug Count
0 RITUXIMAB 19
1 CYCLOPHOSPHAMIDE 14
2 CYCLOPHOSPHAMIDE FOR INJECTION 14
3 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 14
4 METHOTREXATE SODIUM 13
5 METHOTREXATE 12
6 PREDNISONE 11
7 CYTARABINE 10
8 ETOPOSIDE 9
9 FLUDARABINE PHOSPHATE 6
See all common drugs associated with CENTRAL NERVOUS SYSTEM ENTEROVIRAL INFECTION

CENTRAL NERVOUS SYSTEM ENTEROVIRAL INFECTION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 MITOXANTRONE HYDROCHLORIDE 3 0.0005
1 BENDAMUSTINE HCL 3 0.0002
2 CYTARABINE 10 0.0002
3 FLUDARABINE PHOSPHATE 6 0.0002
4 ETOPOSIDE 9 0.0001
5 VINCRISTINE SULFATE 3 0.0001
6 DASPONE 1 0.0001
7 DAPSONE GEL, 5% 1 0.0001
8 DAPSONE 1 0.0001
9 RITUXIMAB 19 0.0001
See all drugs enriched for association with CENTRAL NERVOUS SYSTEM ENTEROVIRAL INFECTION

CENTRAL NERVOUS SYSTEM ENTEROVIRAL INFECTION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Topoisomerase Inhibitor [EPC] 9 0.0001
1 Sulfone [EPC] 1 0.0001
2 CD20-directed Cytolytic Antibody [EPC] 20 0.0001
3 Alkylating Drug [EPC] 14 0.0001
4 Nucleoside Metabolic Inhibitor [EPC] 10 0.0000
5 Folate Analog Metabolic Inhibitor [EPC] 12 0.0000
6 Platinum-based Drug [EPC] 3 0.0000
7 Corticosteroid [EPC] 14 0.0000
See all drug classes enriched for association with CENTRAL NERVOUS SYSTEM ENTEROVIRAL INFECTION